Loading company…
Tokyo-based PharmaBio Corporation develops and manufactures regenerative medicine and cell-based therapy products.
Founded in 1978 and based in Tokyo, Japan, PharmaBio Corporation develops and manufactures regenerative medicine and cell-based therapy products. It provides regulatory support for cell and tissue-derived pharmaceuticals, along with contract development and manufacturing services compatible with GCTP (Good Cell Therapy Practices). In June 2020 the company raised JPY 560.000 mn in Series B funding, including from Alfresa Corporation for a minority stake, at a current valuation of JPY 7,231.346 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in